India’s annual budget boosts ‘ayurveda’ spend
India’s federal budgetary allocation to the so-called Ayush Ministry, which oversees traditional healing systems, has increased by 20 percent to INR3647cr.
Drugs
Health
Pharma
Climate
Health
Uncategorized
Cleaner fuel for passenger jets in the works
Malaysian oil and gas major PETRONAS and the Sarawak Economic Development Corporation (SEDC) have inked a pact to develop technology for microalgae oil
Drugs
Medical
Pharma
Max Healthcare profit jumps 7%, to raise INR 42 billion in debt
Max Healthcare, one of India’s largest private hospital chains, reported a 7% rise in profit after tax, on revenue of INR 15.6 billion,
Health
Medical
Pharma
Junk food increase ovarian, brain cancer risk: UK study
Fizzy drinks, mass-produced breads, many ready meals, and most breakfast cereals increase the risk of cancer as they contain higher salt, fat, sugar
Climate
Health
WMO plans global greenhouse monitoring network
The WMO is working on a plan to gauge heat-trapping atmospheric pollutants on the planet by creating a network of ground-based stations.
Drugs
Medical
Pharma
12 African nations commit to end AIDS in children by 2030
Twelve African nations have drawn out a blueprint to stop AIDS in children by 2030, a move welcomed by the United Nations.
Drugs
Health
Pharma
Stelis Biopharma to be pure play CDMO firm, may list ‘near term’
Stelis Biopharma, a division of India’s Strides Pharma Science, will become a full-fledged contract development and manufacturing firm and may list “near-term.
Drugs
Medical
Pharma
China’s lifting of COVID-19 curbs to ease supply chain disruptions: Glenmark
Glenmark Pharmaceuticals, an Indian global drug maker with a focus on dermatology, respiratory and oncology areas, forecasts lifting of China's COVID-19 curbs may
Climate
Health
Medical
FAO to implement new framework for risk management
A new Framework for Environmental and Social Management was unveiled by the Food and Agriculture Organisation to ensure agrifood systems adhere to global
Drugs
Pharma
India’s pharma market to be worth $130 billion by 2030
The Indian pharmaceutical market is estimated to be worth $130 billion by 2030 from an estimated US$ 41 billion in 2021, the Economic